More recently, THZ1 was shown to inhibit the growth of triple-negative breast cancer (TNBC) and ER+ BC) cells by inhibiting phosphorylation of the RNA Pol II CTD [20] and Ser118 of the ER [21, 22], respectively. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.